OTCMKTS:GSAC GelStat (GSAC) Stock Price, News & Analysis → AI finds its first serious application (From Wall Street Star) (Ad) Free GSAC Stock Alerts $0.0004 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.0004▼$0.000450-Day Range N/A52-Week Range$0.0001▼$0.0017VolumeN/AAverage Volume3.55 million shsMarket Capitalization$247,192.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Get GelStat alerts: Email Address Ad DTIMy top 100 stocks…We recently ran an internal audit of every trade recommendation I’ve published across all my services… And let me tell ya, we found some incredible insights… For starters, we found about 100 stocks I trade really, really well.Get some cool freebies right here. About GelStat Stock (OTCMKTS:GSAC)GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.Read More GSAC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GSAC Stock News HeadlinesSeptember 6, 2022 | marketwatch.comFunctional Chewing Gum Market 2022 | with COVID-19 Pandemic Analysis & Future Growth Analysis by prime Key Players and Regional Forecast 2026August 26, 2022 | marketwatch.comFunctional Chewing Gum Market Is PoIsed to Reflect 5.3%% CAGR by 2027 | 111 Report PagesApril 29, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… August 15, 2022 | reuters.comGSAC.PK - Gelstat Corp | Stock Price & Latest News | ReutersJune 2, 2022 | finance.yahoo.comGelStat Announces $5 Million Public Offering Under Regulation A+June 2, 2022 | finance.yahoo.comGelStat Provides Corporate Update on Capital RestructuringSee More Headlines Receive GSAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GelStat and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/29/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:GSAC CUSIPN/A CIK890725 Webwww.gelstat.com Phone(772) 212-1368Fax888-512-3766Employees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares617,980,000Free Float491,294,000Market Cap$247,192.00 OptionableNot Optionable Beta2.26 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Javier G. AcostaCEO & DirectorMr. Charles F. Tarzian (Age 67)Chief Marketing Advisor Dr. Roger K. Cady M.D.Chief Medical AdvisorKey CompetitorsNovAccess GlobalOTCMKTS:XSNXSkinvisibleOTCMKTS:SKVIAthersysNASDAQ:ATHXAptevo TherapeuticsNASDAQ:APVOTherapix BiosciencesOTCMKTS:TRPXDView All Competitors GSAC Stock Analysis - Frequently Asked Questions How have GSAC shares performed in 2024? GelStat's stock was trading at $0.0003 at the beginning of 2024. Since then, GSAC shares have increased by 33.3% and is now trading at $0.0004. View the best growth stocks for 2024 here. How do I buy shares of GelStat? Shares of GSAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:GSAC) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GelStat Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
